On Monday, 16 March 2026, InMode Ltd (NASDAQ:INMD) participated in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The company outlined its strategic initiatives amidst ...

On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.

Investing.com -- InMode Ltd. (NASDAQ:INMD) shares rose 6.4% Friday following the company’s announcement of a new share repurchase program authorized by its Board of Directors. The medical technology ...

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Microsoft Security Response Center has confirmed that a SQL Server elevation of ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...

This article was published on Feb. 24, 2026, at 10:15 a.m. on the ChosunBiz MoneyMove site. Global aesthetic medical device corporation InMode, listed on the U.S. Nasdaq, has decided to suspend the ...

YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...